Literature DB >> 22875973

Role of interferon regulatory factor 7 in T cell responses during acute lymphocytic choriomeningitis virus infection.

Shenghua Zhou1, Anna M Cerny, Katherine A Fitzgerald, Evelyn A Kurt-Jones, Robert W Finberg.   

Abstract

Type I interferons (IFNs), predominantly IFN-α and -β, play critical roles in both innate and adaptive immune responses against viral infections. Interferon regulatory factor 7 (IRF7), a key innate immune molecule in the type I IFN signaling pathway, is essential for the type I IFN response to many viruses, including lymphocytic choriomeningitis virus (LCMV). Here, we show that although IRF7 knockout (KO) mice failed to control the replication of LCMV in the early stages of infection, they were capable of clearing LCMV infection. Despite the lack of type I IFN production, IRF7 KO mice generated normal CD4(+) T cell responses, and the expansion of naïve CD8(+) T cells into primary CD8(+) T cells specific for LCMV GP(33-41) was relatively normal. In contrast, the expansion of the LCMV NP(396)-specific CD8(+) T cells was severely impaired in IRF7 KO mice. We demonstrated that this defective CD8(+) T cell response is due neither to an impaired antigen-presenting system nor to any intrinsic role of IRF7 in CD8(+) T cells. The lack of a type I IFN response in IRF7 KO mice did not affect the formation of memory CD8(+) T cells. Thus, the present study provides new insight into the impact of the innate immune system on viral pathogenesis and demonstrates the critical contribution of innate immunity in controlling virus replication in the early stages of infection, which may shape the quality of CD8(+) T cell responses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22875973      PMCID: PMC3457134          DOI: 10.1128/JVI.00576-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

1.  Tissue-specific positive feedback requirements for production of type I interferon following virus infection.

Authors:  Arun Prakash; Eric Smith; Chien-Kuo Lee; David E Levy
Journal:  J Biol Chem       Date:  2005-03-14       Impact factor: 5.157

2.  Vaccination against persistent viral infection exacerbates CD4+ T-cell-mediated immunopathological disease.

Authors:  D Hildeman; D Yañez; K Pederson; T Havighurst; D Muller
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

Review 3.  Type I interferons (alpha/beta) in immunity and autoimmunity.

Authors:  Argyrios N Theofilopoulos; Roberto Baccala; Bruce Beutler; Dwight H Kono
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

4.  Priming of CTLs by lymphocytic choriomeningitis virus depends on dendritic cells.

Authors:  Hans Christian Probst; Maries van den Broek
Journal:  J Immunol       Date:  2005-04-01       Impact factor: 5.422

5.  IRF-7 is the master regulator of type-I interferon-dependent immune responses.

Authors:  Kenya Honda; Hideyuki Yanai; Hideo Negishi; Masataka Asagiri; Mitsuharu Sato; Tatsuaki Mizutani; Naoya Shimada; Yusuke Ohba; Akinori Takaoka; Nobuaki Yoshida; Tadatsugu Taniguchi
Journal:  Nature       Date:  2005-03-30       Impact factor: 49.962

6.  Type 1 interferon augments DNA-based vaccination against hepatitis C virus core protein.

Authors:  Stephan Gehring; Stephen H Gregory; Noriyoshi Kuzushita; Jack R Wands
Journal:  J Med Virol       Date:  2005-02       Impact factor: 2.327

7.  Rapid activation of spleen dendritic cell subsets following lymphocytic choriomeningitis virus infection of mice: analysis of the involvement of type 1 IFN.

Authors:  Maria Montoya; Matthew J Edwards; Delyth M Reid; Persephone Borrow
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

8.  Viral immune evasion due to persistence of activated T cells without effector function.

Authors:  A J Zajac; J N Blattman; K Murali-Krishna; D J Sourdive; M Suresh; J D Altman; R Ahmed
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

9.  Two roads diverged: interferon alpha/beta- and interleukin 12-mediated pathways in promoting T cell interferon gamma responses during viral infection.

Authors:  L P Cousens; R Peterson; S Hsu; A Dorner; J D Altman; R Ahmed; C A Biron
Journal:  J Exp Med       Date:  1999-04-19       Impact factor: 14.307

10.  Type I interferons keep activated T cells alive.

Authors:  P Marrack; J Kappler; T Mitchell
Journal:  J Exp Med       Date:  1999-02-01       Impact factor: 14.307

View more
  15 in total

1.  IRF7-dependent type I interferon production induces lethal immune-mediated disease in STAT1 knockout mice infected with lymphocytic choriomeningitis virus.

Authors:  Wen Li; Markus J Hofer; So Ri Jung; Sue-Ling Lim; Iain L Campbell
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

Review 2.  Neuroinflammation During RNA Viral Infections.

Authors:  Robyn S Klein; Charise Garber; Kristen E Funk; Hamid Salimi; Allison Soung; Marlene Kanmogne; Sindhu Manivasagam; Shannon Agner; Matthew Cain
Journal:  Annu Rev Immunol       Date:  2019-04-26       Impact factor: 28.527

3.  IRF9 Prevents CD8+ T Cell Exhaustion in an Extrinsic Manner during Acute Lymphocytic Choriomeningitis Virus Infection.

Authors:  Magdalena Huber; Tamara Suprunenko; Thomas Ashhurst; Felix Marbach; Hartmann Raifer; Svenja Wolff; Thomas Strecker; Barney Viengkhou; So Ri Jung; Hannah-Lena Obermann; Stefan Bauer; Haifeng C Xu; Philipp A Lang; Adomati Tom; Karl S Lang; Nicholas J C King; Iain L Campbell; Markus J Hofer
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

Review 4.  Anti-viral CD8 T cells and the cytokines that they love.

Authors:  Maureen A Cox; Shannon M Kahan; Allan J Zajac
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

5.  Interferon Regulatory Factor 7 Attenuates Chronic Gammaherpesvirus Infection.

Authors:  K E Johnson; C A Aurubin; C N Jondle; P T Lange; V L Tarakanova
Journal:  J Virol       Date:  2020-11-23       Impact factor: 5.103

6.  Ectopic Tcf1 expression instills a stem-like program in exhausted CD8+ T cells to enhance viral and tumor immunity.

Authors:  Qiang Shan; Sheng'en Hu; Xia Chen; Derek B Danahy; Vladimir P Badovinac; Chongzhi Zang; Hai-Hui Xue
Journal:  Cell Mol Immunol       Date:  2020-04-27       Impact factor: 11.530

7.  Type I IFN Signaling Is Dispensable during Secondary Viral Infection.

Authors:  Martin P Hosking; Claudia T Flynn; J Lindsay Whitton
Journal:  PLoS Pathog       Date:  2016-08-31       Impact factor: 6.823

8.  Transcriptome analysis of human peripheral blood mononuclear cells exposed to Lassa virus and to the attenuated Mopeia/Lassa reassortant 29 (ML29), a vaccine candidate.

Authors:  Juan Carlos Zapata; Ricardo Carrion; Jean L Patterson; Oswald Crasta; Yan Zhang; Sachin Mani; Marti Jett; Bhawna Poonia; Mahmoud Djavani; David M White; Igor S Lukashevich; Maria S Salvato
Journal:  PLoS Negl Trop Dis       Date:  2013-09-12

9.  Functional limitations of plasmacytoid dendritic cells limit type I interferon, T cell responses and virus control in early life.

Authors:  Elodie Belnoue; Paola Fontannaz; Anne-Françoise Rochat; Chantal Tougne; Andreas Bergthaler; Paul-Henri Lambert; Daniel D Pinschewer; Claire-Anne Siegrist
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

Review 10.  Type I interferons in viral control and immune regulation.

Authors:  John R Teijaro
Journal:  Curr Opin Virol       Date:  2016-01-24       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.